Suzuki Y - Search Results

1

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria.

Barratt J, Tumlin J, Suzuki Y, Kao A, Aydemir A, Pudota K, Jin H, Gühring H, Appel G; JANUS study investigators. Barratt J, et al. Among authors: suzuki y. Kidney Int Rep. 2022 May 26;7(8):1831-1841. doi: 10.1016/j.ekir.2022.05.017. eCollection 2022 Aug. Kidney Int Rep. 2022. PMID: 35967104 Free PMC article.

2

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy.

Maruyama S, Gohda T, Suzuki Y, Suzuki H, Sonoda Y, Ichikawa S, Li Z, Murakoshi M, Horikoshi S, Tomino Y. Maruyama S, et al. Among authors: suzuki h, suzuki y. Kidney Res Clin Pract. 2016 Dec;35(4):233-236. doi: 10.1016/j.krcp.2016.09.002. Epub 2016 Sep 16. Kidney Res Clin Pract. 2016. PMID: 27957418 Free PMC article.

3

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.

Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J. Yamada K, et al. Among authors: suzuki h, suzuki y. Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov. Kidney Int Rep. 2017. PMID: 29270528 Free PMC article.

4

IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.

Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y. Suzuki H, et al. Among authors: suzuki y. Kidney Int. 2018 Mar;93(3):700-705. doi: 10.1016/j.kint.2017.10.019. Epub 2018 Jan 10. Kidney Int. 2018. PMID: 29329643 Free article.

5

Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis.

Neufeld M, Molyneux K, Pappelbaum KI, Mayer-Hain S, von Hodenberg C, Ehrchen J, Barratt J, Suzuki Y, Sunderkötter C. Neufeld M, et al. Among authors: suzuki y. J Am Acad Dermatol. 2019 Nov;81(5):1078-1085. doi: 10.1016/j.jaad.2019.03.029. Epub 2019 Mar 20. J Am Acad Dermatol. 2019. PMID: 30902725

6

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.

Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG. Myette JR, et al. Among authors: suzuki h, suzuki y. Kidney Int. 2019 Jul;96(1):104-116. doi: 10.1016/j.kint.2019.01.031. Epub 2019 Mar 16. Kidney Int. 2019. PMID: 31027890 Free article.

7

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.

Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y. Makita Y, et al. Among authors: suzuki h, suzuki y. Kidney Int. 2020 Feb;97(2):340-349. doi: 10.1016/j.kint.2019.08.022. Epub 2019 Sep 5. Kidney Int. 2020. PMID: 31748116 Free PMC article.

8

Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.

Barbour SJ, Canney M, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Induruwage D, Er L, Reich HN, Feehally J, Barratt J, Cattran DC; International IgA Nephropathy Network. Barbour SJ, et al. Among authors: suzuki y. Kidney Int. 2020 Oct;98(4):1009-1019. doi: 10.1016/j.kint.2020.04.042. Epub 2020 May 25. Kidney Int. 2020. PMID: 32464215

9

Predictive Value of 1-Week Postoperative Ultrasonography Findings for the Patency Rate of Arteriovenous Fistula.

Shimizu Y, Nakata J, Maiguma M, Shirotani Y, Fukuzaki H, Nohara N, Io H, Suzuki Y. Shimizu Y, et al. Among authors: suzuki y. Kidney Int Rep. 2020 Aug 6;5(10):1746-1752. doi: 10.1016/j.ekir.2020.07.030. eCollection 2020 Oct. Kidney Int Rep. 2020. PMID: 33102967 Free PMC article.

10

Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy.

Kano T, Suzuki H, Makita Y, Fukao Y, Suzuki Y. Kano T, et al. Among authors: suzuki h, suzuki y. Kidney Int. 2021 Aug;100(2):364-376. doi: 10.1016/j.kint.2021.04.026. Epub 2021 May 5. Kidney Int. 2021. PMID: 33961870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,432 results

Search Page